In a skincare market where K-beauty is often associated with discovery and new formats, RoC’s French pharmacy heritage offers a different proposition: formulation, tolerance, clinical evidence and results over time, alongside new formats of its own.
RoC was founded in Paris in 1957 by Dr. Jean-Charles Lissarrague, a Doctor of Pharmacy.
It began partnering with dermatologists on research in 1960.
In 1995, it became the first to stabilize retinol in a skincare product.
More than 30 years later, retinol remains one of the clearest examples of the difference between having an ingredient and developing expertise around it.
RoC’s formulas have been evaluated in more than 250 clinical efficacy and tolerance studies.
Its Patented Clinical Retinol Technology is clinically proven to be 7x more effective than standard retinol* and is used in selected RoC retinol products.
*Based on a clinical study comparing RoC Patented Clinical Retinol with an equal concentration of standard retinol: wrinkle improvement after 12 weeks, 34 subjects.
Over the past five decades, nearly 50 patents have been awarded on RoC innovations. As of 2026, six are active and five of those six relate to retinol.
In 2025, RoC also completed a study benchmarking the stability of 35 retinoid formulas.
For RoC, French pharmacy heritage means a focus on formulation, tolerance, clinical evidence and results over time.



